Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "fluoride release for remineralization" describes the provision of fluoride ions to the tooth surface, typically from dental products such as fluoridated toothpaste, varnishes, or mouthrinses. Fluoride accelerates the growth of fluorapatite crystals in demineralized enamel, making the tissue more resistant to acids from bacteria. It also exhibits antibacterial effects by inhibiting bacterial metabolism and enzyme activity. The main therapeutic value is prevention of dental caries through reversal of early demineralization and enhancement of remineralization[1][2][3][6][7]. This entry is not a target in the molecular sense, but an oral health intervention mechanism, and should not be treated as a therapeutic target such as a receptor or protein.
Provides fluoride ions that incorporate into tooth enamel as fluorapatite, increasing resistance to acid dissolution. Promotes remineralization of demineralized enamel. Inhibits bacterial enzymatic activity and metabolism.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fluoride release for remineralization.